41 episodes

The Lancet Gastroenterology & Hepatology is a monthly journal that considers original research, reviews, and personal views in gastroenterology and hepatology from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.

Listen to The Lancet Gastroenterology & Hepatology The Lancet Gastroenterology & Hepatology

    • Science

The Lancet Gastroenterology & Hepatology is a monthly journal that considers original research, reviews, and personal views in gastroenterology and hepatology from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.

    Anti-TNFα therapy and risk of cancer in patients with immune-mediated diseases

    Anti-TNFα therapy and risk of cancer in patients with immune-mediated diseases

    Dr Akbar Waljee discusses findings from a cohort study investigating the risk of cancer recurrence or a new primary cancer in patients with IBD, rheumatoid arthritis, or psoriasis who received anti-TNFα therapy.

    • 4 min
    Liver damage in young adults

    Liver damage in young adults

    Dr Kushala Abeysekara discusses research looking at the prevalence of non-alcoholic fatty liver disease in young adults in England.

    • 7 min
    Treatments for IBS

    Treatments for IBS

    Professor Alexander Ford discusses a meta analysis comparing different traditional treatments for irritable bowel syndrome.

    • 8 min
    Statins and decompensated cirrhosis

    Statins and decompensated cirrhosis

    Dr. Elisa Pose discusses the potential beneficial effects of statins on the treatment of patients with decompensated cirrhosis

    • 6 min
    Global burden of pancreatic cancer and colorectal cancer

    Global burden of pancreatic cancer and colorectal cancer

    Mohsen Naghavi describes the key findings from two new Global Burden of Disease studies investigating the global burden of pancreatic cancer and colorectal cancer.

    • 14 min
    Paediatric inflammatory bowel disease

    Paediatric inflammatory bowel disease

    Viktor Wintzell joins The Lancet Gastroenterology & Hepatology to discuss the risk of serious infection after use of tumour necrosis factor-α inhibitors in children with inflammatory bowel disease.

    • 7 min

Top Podcasts In Science

Listeners Also Subscribed To